1stOncology™: Cancer Intelligence Service – Page 15082 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Business Results for the year Ended December 31, 2017(unaudited) [PDF](404KB)

On February 14, 2018 Kuraray reported Business Results for the Fiscal Year Ended
December 31, 2017 (Press release, Kuraray, FEB 13, 2018, View Source [SID1234524012]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Ziopharm Oncology to Announce Fourth Quarter and Full Year 2017 Year-end Financial Results and Host Conference Call on March 1

On February 13, 2018 Ziopharm Oncology, Inc. (Nasdaq:ZIOP), reported that management will host a conference call and webcast slide presentation on Thursday, March 1, at 4:30 p.m. ET to provide a corporate update and discuss financial results for the fourth quarter and year ended Dec. 31, 2017 (Press release, Ziopharm, FEB 13, 2018, View Source [SID1234523991]).

The call can be accessed by dialing 1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international). The passcode for the conference call is 3782628. To access the slides and live webcast or the subsequent archived recording, visit the "Investors & Media" section of the Ziopharm website at www.ziopharm.com. The webcast will be recorded and available for replay on the Company’s website for two weeks.

Supernus to Host Fourth Quarter and Full Year 2017 Earnings Conference Call

On February 13, 2018 Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, reported that the Company expects to report the financial results for the fourth quarter and full year of 2017 after 5:00 PM ET on Tuesday, February 27, 2018 (Filing, 8-K, Supernus, FEB 13, 2018, View Source [SID1234523986]).

Jack Khattar, President and Chief Executive Officer, and Greg Patrick, Chief Financial Officer, will host a conference call to present the fourth quarter and full year 2017 business results on Wednesday, February 28, 2018 at 9:00 AM ET. Following the management presentation, the call will be open for questions.

A live webcast will be available at www.supernus.com.

Please refer to the information below for conference call dial-in information. Callers should dial in approximately 10 minutes prior to the start of the call.

Conference dial-in:

(877) 288-1043

International dial-in:

(970) 315-0267

Conference ID:

9385269

Conference Call Name:

Supernus Pharmaceuticals Fourth Quarter and Full Year 2017 Earnings Conference Call

Following the live call, a replay will be available on the Company’s website under the ‘Investors’ section. The webcast will be available on the Company’s website for 60 days following the live call.

RedHill Biopharma to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call on February 22, 2018

On February 13, 2018 RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal diseases and cancer, reported that it will report its fourth quarter and full-year 2017 financial results on Thursday, February 22, 2018 (Press release, RedHill Biopharma, FEB 13, 2018, View Source [SID1234523982]).

The Company will host a conference call on Thursday, February 22, 2018 at 9:00 am EST to review the financial results and business highlights.

To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call: United States: +1-800-281-7829; International: +1-646-828-8143; and Israel: +972-3-721-9463. The access code for the call is: 2134987.

The conference call will be broadcasted live and will be available for replay on the Company’s website, View Source, for 30 days. Please access the Company’s website at least 15 minutes ahead of the conference call to register, download and install any necessary audio software.

KemPharm to Present at the RBC Capital Markets 2018 Global Healthcare Conference

On February 13, 2018 KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, reported that the Company’s Chairman, President and Chief Executive Officer, Travis Mickle, Ph.D., will present at the RBC Capital Markets 2018 Global Healthcare Conference being held February 21-22, 2018, at the Lotte New York Palace Hotel (Press release, KemPharm, FEB 13, 2018, View Sourcenews-releases/news-release-details/kempharm-present-rbc-capital-markets-2018-global-healthcare" target="_blank" title="View Sourcenews-releases/news-release-details/kempharm-present-rbc-capital-markets-2018-global-healthcare" rel="nofollow">View Source [SID1234523954]).

Details of KemPharm’s presentations are as follows:

Event: RBC Capital Markets 2018 Global Healthcare Conference
Date: Wednesday, February 21, 2018
Time: 4:05 PM (EST)
Location: Lotte New York Palace Hotel, Holmes Room #2, New York, NY
The presentation webcast will available on the Investor Relations section of the KemPharm website at View Source following delivery at the conference.